The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

Investigational treatment improves outcomes without complete complement blockade ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

D-Wave Quantum stock gains attention amid institutional activity and quantum computing developments. Explore key drivers ...

Last October, commuters travelling along ­Craigflower Road might have noticed the­ ­sudden disappearance of a familiar ...

The New England Botanic Garden at Tower Hill in Boylston is the kind of place that makes you wonder what else you’ve been ...

It was mainly African Americans, and especially free Blacks, who manned the batteaux that carried crops down Virginia rivers ...

In this valuable study, the authors develop new approaches to investigate mRNA imprinting, a phenomenon in which RNA-protein complexes form in the nucleus to influence the fate of transcripts in the ...

University of Oregon researchers have developed an AI-physics hybrid tool to predict how drug-like molecules move and interact in the body before lab testing. The method preserves key physical details ...